Quantcast
Channel: The Addi and Cassi Fund - Niemann Pick Type C » AIDS Drug
Browsing latest articles
Browse All 5 View Live

Cyclodextrin As A Therapeutic “Drug” For HIV AIDS, Niemann Pick Type C and...

Addi and Cassi’s first round of cyclodextrin infusions have been going smoothly at Renown Regional Medical Center in Reno, Nevada.   We’re now into our third day of continuous infusions of hydroxy...

View Article



Crossing The Blood Brain Barrier – Does Cyclodextrin Make Its Way Into The...

Dr. David Begley, one of the world’s leading blood brain barrier experts at Kings College London is working on a research project we are currently funding on cyclodextrin and the blood brain barrier....

View Article

A Promising Compound That Could Stop HIV AIDS. Why Is It Not Being Supported?

In chapter 18 of a book by Stefano Bertozzi referenced by famous health economist Robert H. Topel in his article in the Journal of Political Economy, several insightful comments about HIV research...

View Article

Journal Of Virology Reports On Link Between HIV and Niemann Pick Cholesterol...

Journal of Virology May 27, 2009 Deficiency of Niemann-Pick type C-1 Protein Impairs HIV-1 Release and Results in Gag Accumulation in Late Endosomal/Lysosomal Compartments Tang Y, Leao IC, Coleman EM,...

View Article

Wacker Chemie Expands US Based Cyclodextrin Facility – Sugar Compound Poses...

Wacker Chemie, the Munich-based chemical company, announced that is has expanded its US based cyclodextrin facility in Eddyville, Iowa.  According the the press release issued by Wacker, the new...

View Article

Browsing latest articles
Browse All 5 View Live




Latest Images